TrialBritish journal of cancer2013

S-1 plus irinotecan and oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: a prospective phase II study and pharmacogenetic analysis.

S Y Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.